TrialBMC cancer2022

Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q - IMPROVE CODEL: the NOA-18 trial.

A Wick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.